Arax Advisory Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Arax Advisory Partners’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8K	Buy	+2,051	New	+$10.8K	﹤0.01%	4287
2025 Q4	–	Sell	-3,939	Closed	-$19.9K	–	4124
2025 Q3	$19.9K	Buy	+3,939	New	+$17.4K	﹤0.01%	2264
2025 Q2	–	Sell	-5,548	Closed	-$15.1K	–	3053
2025 Q1	$15.1K	Sell	5,548 -2	-0%	-$7	﹤0.01%	1423
2024 Q4	$23.6K	Buy	5,550 +100	+2%	+$381	﹤0.01%	1147
2024 Q3	$16K	Hold	5,450	–	–	﹤0.01%	1175
2024 Q2	$19K	Buy	5,450 +2	+0%	+$7	﹤0.01%	985
2024 Q1	$15.5K	Hold	5,448	–	–	﹤0.01%	709
2023 Q4	$19.2K	Hold	5,448	–	–	﹤0.01%	656
2023 Q3	$14.1K	Hold	5,448	–	–	﹤0.01%	650
2023 Q2	$21.5K	Hold	5,448	–	–	﹤0.01%	574
2023 Q1	$18.4K	Hold	5,448	–	–	﹤0.01%	597
2022 Q4	$19.5K	Hold	5,448	–	–	﹤0.01%	563
2022 Q3	$22K	Hold	5,448	–	–	﹤0.01%	554
2022 Q2	$24K	Hold	5,448	–	–	﹤0.01%	536
2022 Q1	$46K	Hold	5,448	–	–	0.01%	465
2021 Q4	$48K	Buy	5,448 +5,000	+1,116%	+$47.5K	0.01%	465
2021 Q3	$5K	Hold	448	–	–	﹤0.01%	751
2021 Q2	$5K	Buy	+448	New	+$4.42K	﹤0.01%	753
2020 Q4	$10K	Buy	+895	New	+$9.13K	﹤0.01%	567

Other funds holding SRTA

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $366M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arax Advisory Partners's SRTA Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 2,051 shares worth $10.8K. The stake represents ﹤0.01% of the portfolio and ranks #4287 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in SRTA as recently as Q3 2025.

Arax Advisory Partners first reported a position in SRTA in Q4 2020 and has held it in 19 quarters since. The position peaked at $48K in Q4 2021. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

Arax Advisory Partners held 2,051 shares of Strata Critical Medical Inc worth $10.8K as of Q2 2026.
Strata Critical Medical Inc was a new Arax Advisory Partners position in Q2 2026.
Strata Critical Medical Inc made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4287 holding.
Arax Advisory Partners first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 19 quarters since.
Arax Advisory Partners's Strata Critical Medical Inc position peaked at $48K in Q4 2021.
139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.